Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tachycardia, Supraventricular | 4 | 2025 | 104 | 2.340 |
Why?
|
| Pacemaker, Artificial | 5 | 2025 | 193 | 1.930 |
Why?
|
| Cardiac Pacing, Artificial | 5 | 2026 | 135 | 1.810 |
Why?
|
| Heart Defects, Congenital | 8 | 2026 | 1889 | 1.640 |
Why?
|
| Atrial Flutter | 2 | 2025 | 44 | 1.620 |
Why?
|
| Heart Rate | 4 | 2026 | 577 | 1.490 |
Why?
|
| Arrhythmias, Cardiac | 8 | 2025 | 482 | 1.050 |
Why?
|
| Cardiomyopathies | 4 | 2026 | 514 | 1.050 |
Why?
|
| Defibrillators, Implantable | 4 | 2024 | 215 | 1.000 |
Why?
|
| Atrial Fibrillation | 3 | 2023 | 738 | 1.000 |
Why?
|
| Bundle of His | 1 | 2026 | 17 | 0.930 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2026 | 49 | 0.880 |
Why?
|
| Heart Arrest | 3 | 2025 | 356 | 0.850 |
Why?
|
| Atrioventricular Block | 1 | 2025 | 45 | 0.840 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2025 | 187 | 0.780 |
Why?
|
| Hospital Mortality | 3 | 2022 | 1064 | 0.770 |
Why?
|
| Wolff-Parkinson-White Syndrome | 2 | 2022 | 73 | 0.750 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2022 | 32 | 0.710 |
Why?
|
| Adenosine | 1 | 2022 | 116 | 0.670 |
Why?
|
| Action Potentials | 2 | 2026 | 476 | 0.640 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2018 | 682 | 0.630 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2019 | 45 | 0.590 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2020 | 132 | 0.570 |
Why?
|
| Catheter Ablation | 1 | 2022 | 324 | 0.560 |
Why?
|
| Ventilator Weaning | 1 | 2018 | 30 | 0.560 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2018 | 137 | 0.550 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2018 | 40 | 0.540 |
Why?
|
| Lung Transplantation | 1 | 2022 | 363 | 0.530 |
Why?
|
| Anti-Arrhythmia Agents | 6 | 2025 | 227 | 0.520 |
Why?
|
| Stroke Volume | 2 | 2026 | 541 | 0.510 |
Why?
|
| Sodium | 1 | 2018 | 280 | 0.500 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2018 | 130 | 0.500 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 362 | 0.490 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2018 | 500 | 0.490 |
Why?
|
| Child | 21 | 2026 | 26341 | 0.490 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2023 | 161 | 0.470 |
Why?
|
| Heart-Assist Devices | 1 | 2025 | 1020 | 0.470 |
Why?
|
| Electrocardiography | 5 | 2025 | 970 | 0.460 |
Why?
|
| Postoperative Care | 1 | 2016 | 294 | 0.420 |
Why?
|
| Heart Block | 2 | 2024 | 37 | 0.400 |
Why?
|
| Bradycardia | 2 | 2025 | 58 | 0.390 |
Why?
|
| Child, Preschool | 13 | 2025 | 15110 | 0.390 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2025 | 64 | 0.390 |
Why?
|
| Adolescent | 15 | 2026 | 20987 | 0.390 |
Why?
|
| Humans | 36 | 2026 | 131163 | 0.390 |
Why?
|
| Systole | 1 | 2013 | 195 | 0.380 |
Why?
|
| Diastole | 1 | 2013 | 181 | 0.380 |
Why?
|
| Retrospective Studies | 16 | 2025 | 17753 | 0.370 |
Why?
|
| Burns | 1 | 2013 | 92 | 0.370 |
Why?
|
| Time Factors | 4 | 2026 | 6196 | 0.340 |
Why?
|
| Tachycardia, Ventricular | 2 | 2025 | 257 | 0.330 |
Why?
|
| Male | 21 | 2026 | 64957 | 0.320 |
Why?
|
| Death, Sudden, Cardiac | 5 | 2025 | 268 | 0.300 |
Why?
|
| Heart Failure | 4 | 2023 | 2332 | 0.280 |
Why?
|
| Sotalol | 3 | 2023 | 33 | 0.270 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1168 | 0.260 |
Why?
|
| Postoperative Complications | 1 | 2020 | 3147 | 0.260 |
Why?
|
| Length of Stay | 1 | 2013 | 1421 | 0.260 |
Why?
|
| Female | 18 | 2026 | 70963 | 0.240 |
Why?
|
| Infant | 10 | 2025 | 13352 | 0.240 |
Why?
|
| Infant, Newborn | 5 | 2025 | 8635 | 0.230 |
Why?
|
| Hemiplegia | 2 | 2025 | 40 | 0.230 |
Why?
|
| Treatment Outcome | 6 | 2026 | 12936 | 0.230 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2025 | 50 | 0.220 |
Why?
|
| Desmoplakins | 1 | 2024 | 12 | 0.220 |
Why?
|
| Ventricular Function, Right | 1 | 2026 | 126 | 0.220 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2024 | 18 | 0.220 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2024 | 61 | 0.210 |
Why?
|
| Adult | 5 | 2026 | 31282 | 0.200 |
Why?
|
| Sinus Arrest, Cardiac | 1 | 2023 | 5 | 0.200 |
Why?
|
| Cardiac Electrophysiology | 1 | 2023 | 15 | 0.200 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2025 | 242 | 0.190 |
Why?
|
| Dexmedetomidine | 1 | 2023 | 46 | 0.190 |
Why?
|
| Tachycardia | 1 | 2022 | 66 | 0.180 |
Why?
|
| Hypnotics and Sedatives | 1 | 2023 | 132 | 0.180 |
Why?
|
| Ventricular Function, Left | 1 | 2026 | 549 | 0.180 |
Why?
|
| Pediatricians | 1 | 2023 | 78 | 0.180 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 2021 | 12 | 0.180 |
Why?
|
| Exercise Test | 1 | 2022 | 239 | 0.170 |
Why?
|
| Amiodarone | 1 | 2021 | 48 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2025 | 1559 | 0.170 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 5196 | 0.170 |
Why?
|
| Ataxia | 1 | 2022 | 160 | 0.170 |
Why?
|
| Ventricular Fibrillation | 1 | 2021 | 51 | 0.170 |
Why?
|
| Heart Atria | 1 | 2022 | 343 | 0.150 |
Why?
|
| DNA | 1 | 2025 | 1399 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 629 | 0.150 |
Why?
|
| Isolated Heart Preparation | 1 | 2018 | 4 | 0.140 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2022 | 468 | 0.140 |
Why?
|
| Intellectual Disability | 1 | 2025 | 1089 | 0.140 |
Why?
|
| Genetic Testing | 1 | 2025 | 1106 | 0.140 |
Why?
|
| Phenotype | 2 | 2025 | 4497 | 0.140 |
Why?
|
| Spectrin | 1 | 2018 | 70 | 0.130 |
Why?
|
| Cardiomegaly | 1 | 2018 | 117 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2018 | 1571 | 0.130 |
Why?
|
| Anticoagulants | 1 | 2022 | 605 | 0.130 |
Why?
|
| Serine | 1 | 2018 | 161 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2020 | 483 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2023 | 5063 | 0.130 |
Why?
|
| Seizures | 1 | 2022 | 890 | 0.130 |
Why?
|
| Point Mutation | 1 | 2018 | 333 | 0.130 |
Why?
|
| Heart Transplantation | 1 | 2023 | 800 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 229 | 0.120 |
Why?
|
| Risk Factors | 7 | 2025 | 11074 | 0.120 |
Why?
|
| Young Adult | 3 | 2026 | 10103 | 0.120 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 2326 | 0.120 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 228 | 0.120 |
Why?
|
| Age Factors | 2 | 2020 | 2825 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2020 | 749 | 0.110 |
Why?
|
| DNA-Binding Proteins | 1 | 2023 | 1939 | 0.110 |
Why?
|
| Echocardiography | 1 | 2020 | 1125 | 0.100 |
Why?
|
| Smoke Inhalation Injury | 1 | 2013 | 8 | 0.100 |
Why?
|
| Dobutamine | 1 | 2013 | 48 | 0.100 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 1410 | 0.090 |
Why?
|
| Epinephrine | 1 | 2013 | 150 | 0.090 |
Why?
|
| Cardiotonic Agents | 1 | 2013 | 138 | 0.090 |
Why?
|
| Dopamine | 1 | 2013 | 246 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2013 | 246 | 0.090 |
Why?
|
| Creatinine | 1 | 2013 | 398 | 0.090 |
Why?
|
| Surgical Procedures, Operative | 1 | 2013 | 225 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 3061 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2013 | 501 | 0.080 |
Why?
|
| Fibrosis | 2 | 2023 | 429 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 4738 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4697 | 0.070 |
Why?
|
| Prevalence | 2 | 2025 | 2701 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2018 | 4686 | 0.060 |
Why?
|
| Mutation | 3 | 2025 | 6099 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 2904 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 4886 | 0.050 |
Why?
|
| Electric Countershock | 1 | 2024 | 74 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2024 | 122 | 0.050 |
Why?
|
| Age of Onset | 1 | 2025 | 592 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2025 | 3436 | 0.050 |
Why?
|
| Animals | 3 | 2023 | 33912 | 0.050 |
Why?
|
| Pericardium | 1 | 2024 | 103 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2023 | 50 | 0.050 |
Why?
|
| Administration, Intravenous | 1 | 2023 | 173 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2023 | 145 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 294 | 0.050 |
Why?
|
| Verapamil | 1 | 2022 | 43 | 0.050 |
Why?
|
| Propranolol | 1 | 2022 | 110 | 0.050 |
Why?
|
| Isoproterenol | 1 | 2022 | 85 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2023 | 3711 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2023 | 531 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2023 | 6459 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2022 | 138 | 0.040 |
Why?
|
| Magnesium | 1 | 2022 | 114 | 0.040 |
Why?
|
| Equipment Design | 1 | 2023 | 512 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 2023 | 316 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2022 | 283 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 43 | 0.040 |
Why?
|
| Acute Disease | 1 | 2023 | 1153 | 0.040 |
Why?
|
| Chromosome Deletion | 1 | 2023 | 653 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2022 | 345 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 274 | 0.040 |
Why?
|
| Registries | 1 | 2025 | 1634 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3359 | 0.030 |
Why?
|
| Fontan Procedure | 1 | 2019 | 180 | 0.030 |
Why?
|
| Genotype | 1 | 2021 | 2595 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2023 | 3819 | 0.030 |
Why?
|
| Cardiac Catheterization | 1 | 2019 | 630 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 18301 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2023 | 2406 | 0.020 |
Why?
|
| Algorithms | 1 | 2020 | 1680 | 0.020 |
Why?
|
| Hospitalization | 1 | 2022 | 1950 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7512 | 0.020 |
Why?
|
| United States | 1 | 2024 | 12072 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 21025 | 0.010 |
Why?
|